Pitt Researchers Find Way To Block Cellular Growth Pathways And Inhibit Tumor Growth

March 31, 1998

At the annual American Association of Cancer Research meeting in New Orleans, University of Pittsburgh Cancer Institute (UPCI) researchers are presenting exciting evidence from animal models that blocking two cellular growth pathways causes tumor cells to die. "We are currently designing a clinical trial for patients with head and neck cancer based on the extremely encouraging results we have seen in these studies," said Jennifer Grandis, M.D., co-director of UPCI's Head and Neck Cancer Center and assistant professor of otolaryngology.

The researchers based their experimental therapy on TGF-" (transforming growth factor alpha) and EGFR (epidermal growth factor receptor). TGF-" binds to EGFR, causing cell division. Both proteins are produced in abnormally high levels by tumor cells, suggesting that they play an important role in maintaining cancer growth. In their research, Dr. Grandis and her colleagues created genetic sequences that block the translation of the genes for TGF-" and EGFR into TGF-" and EGFR proteins. The investigators injected these agents into head and neck tumors growing in laboratory mice. This "antisense" therapy effectively inhibited tumor growth and resulted in cancer cell death, or apoptosis.
-end-


University of Pittsburgh Medical Center

Related Tumor Cells Articles from Brightsurf:

A more sensitive way to detect circulating tumor cells
Breast cancer is the most frequently diagnosed cancer in women, and metastasis from the breast to other areas of the body is the leading cause of death in these patients.

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

How to prevent the spread of tumor cells via the lymph vessels
Scientists from the German Cancer Research Center and the Mannheim Medical Faculty of the University of Heidelberg identified a new way to block the dangerous spread of tumor cells via lymphatic vessels.

The CNIO reprograms CRISPR system in mice to eliminate tumor cells without affecting healthy cells
CNIO researchers destroyed Ewing's sarcoma and chronic myeloid leukaemia tumor cells by using CRISPR to cut out the fusion genes that cause them.

Feeding off fusion or the immortalization of tumor cells
Despite all recent progress, cancer remains one of the deadliest human diseases.

How do tumor cells divide in the crowd?
Scientists led by Dr. Elisabeth Fischer-Friedrich, group leader at the Excellence Cluster Physics of Life (PoL) and the Biotechnology Center TU Dresden (BIOTEC) studied how cancer cells are able to divide in a crowded tumor tissue and connected it to the hallmark of cancer progression and metastasis, the epithelial-mesenchymal transition (EMT).

How tumor cells evade the immune defense
Scientists are increasingly trying to use the body's own immune system to fight cancer.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

New pathway to attack tumor cells identified
A study led by the Institut de Neurociències (INc-UAB) describes a new strategy to tackle cancer, based on inducing a potent stress in tumor causing cell destruction by autophagy.

Nutrient deficiency in tumor cells attracts cells that suppress the immune system
A study led by IDIBELL researchers and published this week in the American journal PNAS shows that, by depriving tumor cells of glucose, they release a large number of signaling molecules.

Read More: Tumor Cells News and Tumor Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.